The global oncology nutrition market size was USD 1.86 Billion in 2021 and is expected to register a revenue CAGR of 8.6% during the forecast period. Research & Development (R&D) of elemental formulas and launch of new products for nutrition of cancer patients and increase in awareness regarding benefits of nutrition of cancer patients are key factors driving global oncology nutrition market revenue growth.
Oncology is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. According to World Health Organization (WHO), cancer is the largest cause of death in the world, with approximately 10 million deaths in 2020. Cancer patients under treatment require a healthy diet as it provides strength to combat disease and immunity to deal with side effects of the treatment. According to specialists, diet of cancer patients must contain milk and dairy products, eggs, meat, poultry, fish, tofu, fruits, vegetables, bread, grain, and cereals. In addition, doctors advise cancer patients to consume high-fat and high-calorie diet to avoid weight loss during the therapy. Various side effects such as loss of appetite, swollen face and many more, make it difficult for the patient to consume all the required nutrients. During and after treatment, patients are provided with oncology nutrition to meet their basic nutrition needs, which not only gives energy, but it also helps to recover faster and aids in healing of sores caused by chemotherapy or other therapies.
Increasing investments by major organizations in R&D is expected to drive market revenue growth to a significant extent. Various companies are focusing on development of innovative cancer nutrition products and launch more enhanced oncology nutrition supplements, in order to address the ongoing unmet requirement in the global market and to provide enhanced products for those undergoing therapy. ONCOFOOD, a pioneering European food initiative by EIT Food, which is a European Knowledge and Innovation Community (KIC), is working to produce a new variety of meals that will appeal to cancer patients with swallowing issues and loss of taste. A wide range of 3D printed meals and snacks have been produced for patients with dysphagia or who require a soft diet on a temporary basis. When compared to pureed meal, 3D printed food allows the patient to distinguish between distinct flavors presented in many layers by separating different ingredients inside the dish. ONCOFOOD was created to assist individuals who are suffering from malnutrition and a poor quality of life as a result of treatment side effects.
Request a Sample@ https://qyresearchmedical.com/sample/119025
Driver: Rising demand for proper nourishment of cancer patients
Patient suffering from cancer or receiving cancer treatment need proper nutrition to reduce side effects with the help of oncology dietitian and well-planned diet. These side effects include nausea, constipation, swallowing issues, need for pancreatic enzymes, dehydration and malnutrition. One of the main challenges for cancer patients undergoing treatment is to prevent or mitigate malnutrition. Anorexia (lack of appetite or desire to eat) and cachexia (weakness, weight loss, and fat and muscle loss) are two major causes of malnutrition in cancer patients. Reduced food, poor levels of physical activity, cancer symptoms, and cancer medicines all contribute to malnutrition in around 70% of cancer patients. To prevent malnutrition, there is a high demand for oncology nutrition to fulfill the nutrients required by patients during and after treatment. Rising prevalence of cancer cases is resulting in high importance for proper nourishment of patients which is one of the key factor driving the oncology nutrition market revenue growth. For instance, according to International Agency for Research on Cancer, there were 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Proper nutrition gives patients more energy and enhances their quality of life by reducing the negative effects of cancer treatment and hastening their recovery. The dietetics department at Nottingham University Hospitals (NUH) teamed with the Macmillan Partnership Programme Nottinghamshire and the CAS directorate to conduct a program of nutritional care innovation for cancer patients. Innovative methods, resources, and staff training will be considered in order to expand patient’s access to evidence-based nutritional care, self-management tools, and a landscape of proactive nutritional care. The goal of this project is to improve the quality and accessibility of nutritional treatment for cancer patients while also promoting efficiency to deal with increasing demands and financial pressures.
Restraint: Financial burden of cancer care
As cancer treatment puts patients in a lot of financial trouble, more than half of the cancer patients delay medical treatment owing to financial constraints. Cancer patients aged 45 years and younger, with children, are prone to financial difficulties, as they could still have college loans and mortgages to pay off. Some people have to use their retirement savings or their children’s education funds to compensate for missed fees during cancer treatment, which can have a long-term financial impact. In addition, stringent regulations to be followed for development and launch of oncology nutritional products, long-duration clinical trials, and possibilities of product disapprovals by regulatory bodies, and limited or no reimbursements in various countries are other factors that could hamper revenue growth of the market to some extent.
Based on type, the oncology nutrition market is segmented into head & neck cancer, stomach & gastrointestinal cancer, pancreatic cancer, liver cancer, esophageal cancer, breast cancer, lung cancer, blood cancer, and other cancer.
An estimated 30% to 50% of patients with head & neck cancer experience difficulties with dietary intake and difficulty to consume food before treatment begins. Even those who are not malnourished at the time of diagnosis remain highly susceptible to malnutrition, so significant weight loss in 75% to 80% of patients has been widely reported. Oncology nutrition is being used to meet the basic nutrition requirement of the patients who are suffering from head and neck cancer. Rising number of head and neck cancer patient is driving revenue growth of this segment. According to Cancer.net, head and neck cancer statistics in 2022, approximately 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in United States. Worldwide, an estimated 562,328 people were diagnosed with head and neck cancer in 2020.
Nutritional support is recommended for stomach & gastrointestinal cancer patients to fulfill the required nutrition during and after their treatment due to many side effects such as loss of appetite and issues with digestion, difficulty in swallowing and feeling full after eating small amounts of food. Nutrition could be provided with oral, Enteral Nutrition (EN), and Parenteral Nutrition (PN). Enteral nutrition (EN) has been proven to help maintain intestinal barrier function, immunity, and gut dysbiosis and provide a valid nutritional option for patients with dysphagia or obstruction when the oral intake does not satisfy the nutritional requirements.
Based on end-use, the oncology nutrition market is segmented into hospitals, clinics, and others.
The hospital segment accounted for largest revenue share in 2021. Treatment can have adverse effects, and the patient’s body need proper nourishment both during and after treatment to avoid complications such as malnutrition and dehydration. Rising prevalence of cancer patient worldwide is driving revenue growth of this segment because, in hospitals, oncology nutrition therapy is utilized to assist cancer patients maintain a healthy and balanced body weight and energy.
The clinic segment is expected to register a steady revenue growth rate during the forecast period. Anorexia, decreased food intake, lethargy, weight loss, muscle loss and deterioration in functional ability are all common after treatment effects in patients with advanced cancer. Oncology nutrition is prescribed to cancer patients to meet the nutrition required for faster recovery and to reduce side effects. Nutrition counselling, commercial food supplements, appetite stimulants, enteral nutrition, and parenteral nutrition are among the services provided by clinics to patients, which is driving revenue growth of this segment.
Distribution Channel Insights:
Based on distribution channel, the oncology nutrition market is segmented into hospitals, retail pharmacies, and online pharmacies.
The online pharmacies segment is expected to register a steady revenue growth rate during the forecast period. Online pharmacies have a vast network with medicines of various brands to choose from according to prescription. Increasing trend of buying medicines and other healthcare products from online websites and apps due to benefits offered such as convenience and door-step delivery at any time and wide availability of options compare to offline retail stores are major factors driving revenue growth of this segment.
The retail store segment accounted for significantly large revenue share in 2021. Many people still prefer retail stores over online pharmaceuticals for various advantages such as no time delivery, returning any product is easy in retail stores and people without much knowledge of the digital world can visit retail stores and purchase the exact product they want, which is driving revenue growth of this segment.
Based on stage, the oncology nutrition market is segmented into chemotherapy, hormone therapy, radiation therapy, surgery, immunotherapy, and stem cell transplant.
Chemotherapy segment accounted for largest revenue share in 2021. Chemotherapy can cause side effects as it damages cancerous cell to prevent them from multiplying. Chemotherapy can affect patients’ ability to eat and maintain their current level of nutrition including nausea, vomiting, taste changes, appetite changes, mucositis or mouth sores, fatigue, diarrhea, and/or constipation. Oncology nutrition therapy helps these patients maintain a healthy body weight after chemotherapy, retain strength, maintain healthy body tissue, and reduce adverse effects both during and after treatment.
Radiation therapy segment is expected to register a steady revenue growth rate during the forecast period. Radiation results in extreme weight loss and the degree of weight loss & malnutrition is determined by the part of the patient’s body being treated with radiation, as well as the dose, duration, and volume of treatment. Some of the side effects of radiation therapy include nausea, vomiting, microsites, dysphagia, xerostomia, trismus, diarrhea, enteritis, and malabsorption. After surgery or radiation therapy, extra protein is usually needed to heal tissues and fight infection. However, when a patient is being treated for cancer, eating can be a difficult task, especially if there are any side effects. Oncology nutrition is used to fulfill the nutrition requirements of a patient which is driving revenue growth of this segment.
Nutrition Support Insights:
Based on nutrition support insights, the oncology nutrition market is segmented into enteral nutrition and parenteral nutrition.
Enteral nutrition segment accounted for largest revenue share in 2021. Enteral nutrition has been linked to the preservation of gastrointestinal tract structural integrity, decreased gut permeability, and enhanced mesenteric blood flow. Enteral nutrition has also been linked to lower rates of infection complications, death, Length of Stay (LOS), and expenses in hospitals. Enteral route is preferred as it helps patients to recover faster, thus driving revenue growth of this segment.
Parenteral nutrition segment is expected to register rapid revenue growth rate during the forecast period. Nutrition must be supplied into the patient’s bloodstream, bypassing the gut, if the patient’s gut cannot absorb nutrients. Some of the reasons behind this style of feeding are blockage (obstruction) or failure of the gut to function (ileus), as well as holes in the gut where eating would aggravate infections. Parenteral nutrition is slowly pumped into the circulation via a drip, and because it might irritate blood vessels, it is generally supplied through a central venous line inserted into a large vein near the heart in the upper arm, chest, or neck. Sugar, carbs, proteins, fats, electrolytes, and trace elements are all delivered to the body via parenteral nutrition, which are necessary for sustaining high levels of energy, hydration, and strength.
Based on regional analysis, the oncology nutrition market in North America accounted for largest revenue share in 2021, due to high prevalence of cancer and availability of improved healthcare infrastructure in countries in the region. For instance, according to National Center for Health Statistics, In 2022, the United States is expected to register 1,918,030 new cancer cases and 609,360 cancer deaths, with around 350 deaths per day from lung cancer, which is the main cause of cancer death. In addition, presence of various key companies in countries in this region, and increasing investments in research & development for advance oncological nutrition solution are other factors driving revenue growth of the market in this region.
Asia Pacific market is expected to register a steady revenue growth rate during the forecast period, due to increasing prevalence of various types of cancer, and rising awareness regarding benefits of oncology nutrition among patients to address nutritional requirements of the body before and after cancer treatment. In 2020 for instance, according to WHO, there were an estimated 5 million cancer cases in Asia Pacific and risk of developing cancer before the age of 75 years is 17.5%. In addition, increasing medical tourism in countries such as China, India, Malaysia, Philippines, and Singapore, among others due to availability of cost-effective cancer treatment and increasing initiatives by government of countries in this region and focus on development of healthcare infrastructure and amendments for medical tourists are other key factors driving revenue growth of the market in this region. In 2016 for instance, one of such initiatives was made by government of India to amend E-visa rules for around 150 countries, that made visa procurement process easy for medical tourists. In addition to this, National Health Policy of India, 2002 specifies that the government will support medical tourism and will issue MX visas to the accompanying spouse of the patient.
Europe market is expected to register a steady revenue growth rate during the forecast period due to increasing initiatives by federal organization in Europe such as Europe’s Beating Cancer Plan by European Commission. The aim of Europe’s Beating Cancer Plan is to prevent the use of tobacco with the goal of reducing tobacco use to less than 5% of the population by 2040, as excessive alcohol use, pollution, and toxic chemicals are factors leading to cancer. Moreover, This organization is expected to launch campaigns such as ‘HealthyLifestyle4All’ promoting healthy diet and oncological nutrition, which is expected to drive revenue growth of the market in this region.
Competitive landscape of the oncology market is consolidated with a few key players operating on global and regional levels. Key players are engaged in product development & strategic alliances to expand their respective product portfolios and gain a robust footing in the global market. The companies profiled in the global market report include Abbott Laboratories, Danone SA, Nestle SA, Fresenius Kabi AG, B. Braun Melsungen AG, Mead Johnson & Company, LLC, Hormel Foods Corporation, Meiji Holdings Co., Ltd., Victus Inc., and Global health products Inc.
In April 2020, Esperer Onco Nutrition, which is an India-based startup company, launched a range of nutrition supplements for patients suffering from cancer. These supplements target patients before, during, and after treatment to help patients prevent from cancer-related weight loss.
In 2019, CancerCare entered into a partnership with Savor Health and launched Introduce Ina, the intelligent nutrition assistant. Ina offers personalized, evidence-based nutrition support to help people with cancer to eat healthily and stay well-nourished throughout their treatment and post treatment as well.
Segments Covered in the Report
This report offers historical data and forecasts revenue growth at a global, regional & country-level, and provides analysis of the market trends in each of the sub-segments from 2019 to 2030. For this study, Reports and Data have segmented the global oncology nutrition market based on type, end-use, distribution channel, stage, nutrition support, and region:
Oncology Nutrition Market Report Scope
Segments covered By Type Outlook, End-use Outlook, Distribution Channel Outlook, Stage Outlook, Nutrition Support Outlook, Regional Outlook
By Type Outlook
Head and Neck Cancer
Stomach and Gastrointestinal Cancer
By End-use Outlook
By Distribution Channel Outlook
By Stage Outlook
Stem Cell Transplant
By Nutrition Support Outlook
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/119025/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: